ArticleOncoTargets and therapy2017

Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients.

Mohamed A Daoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.